Search for: "Courtenay Brinckerhoff"
Results 61 - 79 of 79
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Dec 2013, 5:30 pm by Colin O'Keefe
– Miami attorney Jim Walker of Walker & O’Neill on his blog, Cruise Law News Back to the Future with Lloyd Cutler – Raleigh attorney David Smyth of Brooks Pierce on their blog, Cady Bar the Door Communicating Effectively Under Stress – Dykema Chairman & CEO Peter Kellett on his blog, The Business of Serving Clients Monday Morning Regulatory Review – 12/16/13: Obamacare Deadlines; Labor Elections Rule; Swaps Litigation; Vacating Empty… [read post]
22 Aug 2012, 5:57 pm by Jared Sulzdorf
Marcari of Epstein Becker Green on the firm’s Executive Women’s Networking Blog Expanding into Vegetarian Products Lands Starbucks in Hot Water – Minneapolis lawyer Tiffany Blofield of Winthrop & Weinstine on the firm’s Duets Blog $10,000 FCC Fine for Failure to Follow Contest Rules – On-Air Rules Were Right, But Online Rules Were Wrong – Washington, D.C. attorney David Oxenford of Davis Wright Tremaine in the firm’s Broadcast Law Blog NLRB Decision Could Interfere With Workplace… [read post]
24 Aug 2012, 5:20 pm by Jared Sulzdorf
Total posts on the LexBlog Network today: 142 First To File Practice: Commonly Owned Applications – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents “Dismissal for falling asleep at work not automatically unfair” – London lawyer David Whincup of Squire Sanders on the firm’s blog, Employment Law Worldview Concerns About Crowdfunding – Ohio attorney Kevin LaCroix of OakBridge Insurance Services in his blog, The D & O… [read post]
22 Dec 2015, 6:31 pm by Colin O'Keefe
– Philadelphia lawyer Wally Zimolong on his blog, Supplemental Conditions In Search of Leadership With An Authentic Voice – Chief Marketing Officer Eric Fletcher on his blog, Marketing Brain Fodder A Delicious Look At A Cookie Press Patent – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and… [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA.” [read post]
10 Jun 2014, 6:34 pm by Colin O'Keefe
– Dallas lawyer Charles Sartain of Looper Reed & McGraw on Energy And The Law Supreme Court Adopts Reasonable Certainty Test For Definiteness – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents Hershey’s Chocolate Wants to Kill Your Buzz – Seattle lawyer Philip Mann of Mann Law Group on his IP Litigation Blog For more of the best, check out LXBN, a complete review of the top… [read post]
9 May 2014, 9:44 am by Justin E. Gray
  Courtenay Brinckerhoff explains that "the Federal Circuit decision here does not appear to break much new ground, because the burden-shifting framework it supports is common to every issue that examiners raise. [read post]
21 Mar 2012, 8:25 am by Stephanie Figueroa
Check out these fantastic case summaries and opinion pieces: PharmaPatents: Justice Breyer Gets The Last Word And Invalidates Prometheus Personalized Medicine Claims - Courtenay Brinckerhoff provides a thorough summary of the decision in this article. [read post]
8 Jul 2010, 5:00 am by Dennis Crouch
Kappos: Effects on Biotechnology Patents Some New IP Blogs: PharmaPatentsBlog by Courtenay Brinckerhoff and her folks at the Foley law firm. [read post]
25 Mar 2012, 1:05 pm by Antoinette Konski
For additional analysis on Prometheus and its possible impact, see my colleague Courtenay Brinckerhoff’s March 22nd post. [read post]
22 Aug 2007, 10:17 am
I spoke with Courtenay Brinckerhoff at Foley & Lardner briefly about the new rules and she expressed the concern that the rule changes may be especially problematic for the chemical, pharmaceutical and biotech arts. [read post]
20 Mar 2014, 6:14 am by Rob Robinson (Ki Hwang, Geoff Wilcox)Actionable Intelligence for In-House CounselProviding in-house counsel with a weekly overview of significant legal and technology-related stories centered around the corporate risk topics of compliance, information governance, privacy and security.4 Accused in Law Firm Fraud Ignored a Maxim: Don’t Email – (Matthew Goldstein)5 Key Points About Patent Subject Matter Eligibility… [read post]